Clinical usage recommendations and analytic performance goals for total and free triiodothyronine measurements

Clinical Chemistry

Volumn 42, Issue 1, 1996, Pages 155-159

  Klee, George G ^a  

^a MAYO CLINIC   (United States)

Author keywords

amiodarone; analytic variation; biologic variation; hyperthyroidism; hypothyroidism; thyrotoxicosis; thyroxine

Indexed keywords

AMIODARONE; ANTITHYROID AGENT; LIOTHYRONINE; THYROID HORMONE; THYROXINE;

CONFERENCE PAPER; FREE THYROXINE INDEX; GRAVES DISEASE; HORMONE DETERMINATION; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; LABORATORY DIAGNOSIS; LIOTHYRONINE BLOOD LEVEL; PREDICTION; QUANTITATIVE ASSAY;

EID: 0030032835     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.1.155     Document Type: Conference Paper

References (38)

1. Surks MI, Chopra IJ, Mariash CN, Nicoloff JT, Solomon DH. American Thyroid Association guidelines for use of laboratory tests in thyroid disorders. JAMA 1990;263:1529-32.
2. Becker DV, Bigos ST, Gaitan E, Morris JC, Rallison ML, Spencer CA, et al. Optimal use of blood tests for assessment of thyroid function [Letter]. JAMA 1993;269:2736.
3. Bartuska DG, Bergman DA, Bray GA, Coble YD, Fore WW, Hodgson SF, et al. AACE clinical practice guidelines for the evaluation and treatment of hyperthyroidism and hypothyroidism. Jacksonville, FL: American Association of Clinical Endocrinologists, 1995.
4. John R, Henley R, Lloyd G, Elder G. Evaluation of a new strategy for detection of thyroid dysfunction in the routine laboratory. Clin Chem 1988;34:1110-4.
5. Hughes JM, Gallagher DL, Olson JE. Plasma free thyroxine concentrations in patients receiving levothyroxine for thyroid suppression. Surgery 1989;100:951-5.
6. 3), and sensitive thyrotropin (TSH) assay in the assessment of optimal thyroxine therapy. Clin Biochem 1987;20:265-7.
7. Pearce CJ, Himsworth RL. Serum iodothyronine concentrations during introduction of thyroxine replacement therapy in hypothyroidism. Clin Endocrinol (Oxf) 1986;25:303-11.
8. Kabadi UM. Variability of L-thyroxine replacement dose in elderly patients with primary hypothyroidism. J Fam Pract 1987;24: 473-7.
9. Price DE, O'Malley BP, Northover B, Rosenthal FD. Changes in circulating thyroid hormone levels and systolic time intervals in acute hypothyroidism. Clin Endocrinol (Oxf) 1991;35:67-9.
10. Volta C, Ghizzoni L, Davoli A, D'Amato L, Panza C, Bernasconi S. Thyroid function tests in children with congenital hypothyroidism on L-thyroxine treatment. Horm Res 1989;32:109-12.
11. Smyrk TC, Goellner JR, Brennan MD, Carney JA. Pathology of the thyroid in amiodarone-associated thyrotoxicosis. Am J Surg Pathol 1987;11:197-204.
12. Chiovato L, Martino E, Tonacchera M, Santini F, Lapi P, Mammoli C, et al. Studies on the in vitro cytotoxic effect of amiodarone. Endocrinology 1994;134:2277-82.
13. Newnham HH, Topliss DJ, LeGrand BA, Chosich N, Harper RW, Stockigt JR. Amiodarone-induced hyperthyroidism: assessment of the predictive value of biochemical testing and response to combined therapy using propylthiouracil and potassium perchlorate. Aust N Z J Med 1988;18:37-44.
14. Roti E, Minelli R, Gardini E, Bianconi L, Braverman LE. Thyrotoxicosis followed by hypothyroidism in patients treated with amiodarone. Arch Intern Med 1993;153:886-92.
15. Tajiri J, Noguchi S, Morita M, Tamaru M, Murakami N, Kato R. Serum free triiodothyronine to free thyroxine ratio enables early prediction of the outcome of antithyroid drug therapy in patients with Graves' hyperthyroidism. Endocrinol Jpn 1991;38:683-7.
16. Notsu K, Oka N, Masaki Y, Furuya H, Kato Y. Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves' disease treated with antithyroid drugs. J Clin Endocrinol Metab 1991;73:396-400.
17. Novitzky D, Cooper DKC, Human PA, Reichart B, Zuhdi N. Triiodothyronine therapy for heart donor and recipient. J Heart Transplant 1988;7:370-6.
18. Chu S-H, Huang T-S, Hsu R-B, Wang S-S, Wang C-J. Thyroid hormone changes after cardiovascular surgery and clinical implications. Ann Thorac Surg 1991;52:791-6.
19. 3) in low cardiac output following cardioplegic arrest and cardiopulmonary bypass: an initial experience in patients undergoing open heart surgery. Eur J Cardiothorac Surg 1989;3: 140-5.
20. Cooper DKC. Changes in plasma-free thyroid hormones during cardiopulmonary bypass [Letter]. J Thorac Cardiovasc Surg 1992; 104:526-35.
21. Bjorn-Hansen Gotzsche LS, Weeke J. Changes in plasma free thyroid hormones during cardiopulmonary bypass do not indicate triiodothyronine substitution. J Thorac Cardiovasc Surg 1992; 104:273-7.
22. Tanaka K, Kodama S, Yokoyama S, Komatsu M, Konishi H, Momota K, et al. Thyroid function in children with long-term anticonvulsant treatment. Pediatr Neurosci 1987;13:90-4.
23. Larkin JG, Macphee GJA, Beastall GH, Brodie MJ. Thyroid hormone concentrations in epileptic patients. Eur J Clin Pharmacol 1989; 36:213-6.
24. Isojärvi JIT, Pakarinen AJ, Myllylä VV. Thyroid function with antiepileptic drugs. Epilepsia 1992;33:142-8.
25. Chopra IJ, Solomon DH, Huang T-S. Serum thyrotropin in hospitalized psychiatric patients: evidence for hyperthyrotropinemia as measured by an ultrasensitive thyrotropin assay. Metabolism 1990;39:538-43.
26. 3-test values in psychiatric patients treated with orphenadrine. Acta Med Scand 1987;222:375-9.
27. 4 test for thyroid evaluation in lithium treated patients. Can J Psychiatr 1987;32:112-4.
28. Brady KT, Anton RF. The thyroid axis and desipramine treatment in depression. Biol Psychiatr 1989;25:703-9.
29. Thomas DR, Ailwood R, Harris B, Williams PA, Scanlon MF, John R. Thyroid status in senile dementia of the Alzheimer type (SDAT). Acta Psychiatr Scand 1987;76:158-63.
30. Matsubayashi S, Tamai H, Uehata S, Kobayashi N, Mori K, Nakagawa T, et al. Anorexia nervosa with elevated serum TSH. Psychosom Med 1988;50:600-6.
31. Baumgartner A, Campos-Barros A, Meinhold H. Thyroid hormones and depressive illness: implications for clinical and basic research. Acta Med Austriaca 1992;19:98-102.
32. Mak YT, Chan ELP, Woo CJ, Swaminathan R. Free triiodothyronine in sera of acutely ill general medical patients: a prognostic indicator? Clin Chem 1992;38:414-5.
33. Bergmann PJ, Tricht LV. Free triiodothyronine in hypothyroidism and in nonthyroidal illness [Letter]. Clin Chem 1994;40:496-7.
34. Soldin SJ, Hicks JM, eds. Pediatric reference ranges. Washington, DC: AACC Press, 1995:132-3.
35. Elevitch R, ed. College of American Pathologists Conference Report. Conference on analytical goals in clinical chemistry, at Aspen, CO. Skokie, IL: CAP, 1976.
36. Fraser CG, Petersen PH. Desirable standards for laboratory tests if they are to fulfill medical needs. Clin Chem 1993;39:1447-55.
37. Browning MCK, Ford RP, Callaghan SJ, Fraser CG. Intra-and interindividual biological variation of five analytes used in assessing thyroid function: implications for necessary standards of performance and the interpretation of results. Clin Chem 1986; 32:962-6.
38. Browning MCK. Analytical goals for quantities used to assess thyrometabolic status. Ann Clin Biochem 1989;26:1-12.